Screener
TG Therapeutics TGTX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's price / sales?
- TG Therapeutics (TGTX) reported price / sales of 10.5× in Q2 2026.
- How has TG Therapeutics's price / sales changed year-over-year?
- TG Therapeutics's price / sales decreased by 19.3% year-over-year, from 13× to 10.5×.
- What is the long-term trend for TG Therapeutics's price / sales?
- Over 5 years (2020 to 2025), TG Therapeutics's price / sales has grown at a -82.7% compound annual growth rate (CAGR), from 48,920.4× to 7.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about TG Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude